Finance

Lists
Why is 4119 down 2.29%?
Dive Deeper
4119:TPE
SCI Pharmtech Inc
NT$55.40
-2.29%
(-1.30) 1D
Sep 29, 1:30:38 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 4119...
Open
NT$56.70
High
NT$56.90
Low
NT$55.30
Mkt. cap
6.62B
Avg. vol.
202.26K
Volume
112.38K
Dividend
1.35%
Quarterly dividend
NT$0.19
Ex-dividend date
Jul 1, 2026
P/E ratio
110.53
52-wk high
NT$60.80
52-wk low
NT$39.60
EPS
NT$0.50
Shares outstanding
79.48M
No. of employees
241
Open
NT$56.70
High
NT$56.90
Low
NT$55.30
Mkt. cap
6.62B
Avg. vol.
202.26K
Volume
112.38K
Dividend
1.35%
Quarterly dividend
NT$0.19
Ex-dividend date
Jul 1, 2026
P/E ratio
110.53
52-wk high
NT$60.80
52-wk low
NT$39.60
EPS
NT$0.50
Shares outstanding
79.48M
No. of employees
241
About SCI Pharmtech Inc
CEO-
Employees241
Founded1987
Headquarters-
SectorPharmaceutical industry
Websitesci-pharmtech.com.tw
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
256.44M
355.47M
375.80M
272.86M
Cost of goods sold
188.07M
255.88M
293.47M
218.00M
Cost of revenue
188.07M
255.88M
293.47M
218.00M
Research and development expenses
8.88M
9.82M
9.10M
10.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
40.76M
46.98M
40.07M
35.42M
Operating expense
49.64M
56.80M
49.17M
45.53M
Total operating expenses
237.71M
312.67M
342.65M
263.53M
Operating income
18.73M
42.80M
33.15M
9.34M
Other non operating income
2.31M
4.19M
5.32M
2.52M
EBT including unusual items
17.80M
42.28M
28.59M
-12.60M
EBT excluding unusual items
17.84M
42.23M
28.56M
-12.60M
Income tax expense
3.81M
3.42M
8.48M
248.00K
Effective tax rate
21.39%
8.10%
29.66%
-1.97%
Other operating expenses
-
-
-
-
Net income
14.00M
38.86M
20.11M
-12.85M
Net profit margin
5.46%
10.93%
5.35%
-4.71%
Earnings per share
-
-
-
-
Interest and investment income
789.00K
578.00K
1.00K
359.00K
Interest expense
-1.12M
-1.81M
-2.08M
-2.51M
Net interest expenses
-336.00K
-1.23M
-2.08M
-2.15M
Depreciation and amortization charges
-
-
-
-
EBITDA
80.72M
104.97M
95.55M
72.04M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps